• KOL
    • Lupus Erythematosus
    • Arthi Reddy
    • Arthi Reddy: Influence Statistics

      Arthi Reddy

      Arthi Reddy

      From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Arthi Reddy:Expert Impact

      Concepts for whichArthi Reddyhas direct influence:Lupus erythematosus,Systemic lupus erythematosus,Efficacy belimumab,Patients sle,Belimumab benlysta,Belimumab sle,Systemic lupus,Onset antibodies.

      Arthi Reddy:KOL impact

      Concepts related to the work of other authors for whichfor which Arthi Reddy has influence:Systemic lupus erythematosus,Belimumab patients,Treatment sle,Lupus nephritis,Biological therapies,Maintenance therapy,Damage progression.

      KOL Resume for Arthi Reddy

      Year
      2015

      From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center, New York; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; Medical University of South Carolina, Charleston, South Carolina; Temple University School of Medicine, Philadelphia, Pennsylvania; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Karolinska University Hospital, Stockholm, Sweden; Cedars-Sinai Medical Center, Los Angeles, California, USA.J.S. Hui-Yuen, MD, MSc, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A. Reddy, BSc, Research Assistant, New York University Langone Medical Center; J. Taylor, MD, Pediatric Resident, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; X. Li, BSc, Research Assistant, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; A.H. Eichenfield, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.M. Bermudez, MD, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A.J. Starr, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.F. Imundo, MD, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; J. Buyon, MD, Professor, New York University Langone Medical

      2013

      Nyu School of Medicine

      Sample of concepts for which Arthi Reddy is among the top experts in the world.
      Concept World rank
      medications belimumab #13
      soluble lymphocyte stimulator #23
      belimumab benlysta #23
      benlysta #41
      soluble blymphocyte stimulator #41
      initiation belimumab #42
      onset antibodies monoclonal #96
      efficacy belimumab #98

      Prominent publications by Arthi Reddy

      KOL-Index: 8529

      OBJECTIVE: To evaluate the use and efficacy of belimumab in academic practices. Belimumab is a human monoclonal antibody that inhibits soluble B lymphocyte stimulator and has been approved for the treatment of adults with systemic lupus erythematosus (SLE).

      METHODS: Invitations to participate and complete a 1-page questionnaire for each patient prescribed belimumab were sent to 16 physicians experienced in SLE phase III clinical trials. The outcome was defined as the physician's ...

      Known for Lupus Erythematosus | Patients Sle | 6 Months | Onset Antibodies | Efficacy Belimumab

      Key People For Lupus Erythematosus

      Top KOLs in the world
      #1
      David Alan Isenberg
      systemic lupus erythematosus patients sle rheumatoid arthritis
      #2
      Michelle A Petri
      systemic lupus erythematosus lupus nephritis patients sle
      #3
      D Gladman Gladman
      psoriatic arthritis systemic lupus erythematosus patients psa
      #4
      Murray B Urowitz
      systemic lupus erythematosus patients sle lupus nephritis
      #5
      James F Fries
      rheumatoid arthritis physical function systemic lupus erythematosus
      #6
      Eng M Tan
      antinuclear antibodies hepatocellular carcinoma cell nuclear antigen

      From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.